Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors

2017 ◽  
Vol 32 (8) ◽  
pp. 1711-1718 ◽  
Author(s):  
Yue Huang ◽  
Fenglin Zhuo ◽  
Linfeng Li
Menopause ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Allison M. Quick ◽  
Filadelfiya Zvinovski ◽  
Catherine Hudson ◽  
Andrew Hundley ◽  
Cynthia Evans ◽  
...  

Maturitas ◽  
2021 ◽  
Vol 144 ◽  
pp. 37-44
Author(s):  
Allison M. Quick ◽  
Travis Dockter ◽  
Jennifer Le-Rademacher ◽  
Ritu Salani ◽  
Catherine Hudson ◽  
...  

2014 ◽  
Vol 38 (5) ◽  
pp. 839-848 ◽  
Author(s):  
Amanda C. Moreira ◽  
Marcio Moreira ◽  
Roberta L. Motta ◽  
Yasmin C. Moreira ◽  
Ana P. Bettoni ◽  
...  

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Mahmoud Abdel Reheem Abdallah ◽  
Azza Esmat Mostafa ◽  
Shawkat Mohammad Abdel Hameed Mohammad

Abstract Background Striae distensae are a well-recognized, common skin condition that rarely causes any significant medical problems but are often a significant source of distress to those affected. The natural evolution of striae is from red or purple, raised wavy lesions (striae rubra) to white atrophic lesions with wrinkly surface (striae alba). Objectives The present study was designed to compare the efficacy of fractional CO2 laser alone or combined with lyophilized growth factors or to its efficacy alone in the treatment of striae distensae. Patients and Methods The present study included 20 female patients with SD; they were all recruited from Dermatology Outpatient Clinic, Ain Shams University from may 2017 to march 2018. An informed consent for treatment, photography and punch biopsy was taken before enrollment and the study was approved by Dermatology Research Ethical Committee. Results The present study showed statistically significant clinical and histopathological improvement in areas A and B after treatment. This impronment was in rubra more than alba. Area C showed no clinical and histopathological improvement. Area B showed better results than area A.We propose that LGF alone did not show clinical or histopathologiacl improvement. Treatment was tolerated well by all patients where side effects were minimal in the form of transient PIH that resolved after using bleaching creams. There was no statistically sgnificant difference in the incidence of PIH between areas A& B. Conclusion We concluded that fractional CO2 alone is effective in treatment of SD especially stria rubra in skin type III and IV.


Author(s):  
Zinat Ghanbari ◽  
Samira Sohbati ◽  
Tahereh Eftekhar ◽  
Leyla Sahebi ◽  
Soodabeh Darvish ◽  
...  

Objective: The aim of this study was to evaluate the safety and efficacy of fractional CO2 laser for treatment of vulvovaginal atrophy. Materials and methods: In this clinical trial study, we evaluated the laser effect on vulvovaginal atrophy in 47 women aged 43-80 years. Each woman was treated with fractional CO2 laser, SmartXide2V2LR, DEKA, Monalisa Touch, vaginal 360o probe and cosmetic probe. The severity of vulvovaginal atrophy symptoms was evaluated before first session of laser and every 4 weeks after laser treatment until 12 weeks. Adverse effects including pain and itching were assessed at all visits. The statistical analysis was performed using SPSS version 23. Results: The response to laser therapy for vaginal dryness was significantly (p <0.001) improved. Also, the response to laser therapy for each symptom include dyspareunia, vaginal discharge, itching and urge urinary incontinence was statistically significant (p <0.001) based on visual analogue scale (VAS). Conclusion: It seems vaginal fractional CO2 laser can be applied as an effective and safe treatment method in genitourinary syndrome of menopause (GSM). It is necessary to conduct studies with long-term follow-up.


2020 ◽  
Vol 83 (6) ◽  
pp. AB189
Author(s):  
Elizabeth Morehouse Pearce ◽  
Dr. R. Rox Anderson ◽  
Dr. Yen-Lin Chen ◽  
Dr. Thanh-Nga Tran

Sign in / Sign up

Export Citation Format

Share Document